Trials / Completed
CompletedNCT02043197
Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder
Post-Marketing Observational Program of Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorders (FRIENDS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter, non-comparative, observational program to describe prevalence of depressive symptoms in a variety of neurological disorders and effects of Fevarin® on the severity of anxiety and depression, sleep state, and cognitive function.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2014-01-23
- Last updated
- 2018-12-17
- Results posted
- 2018-12-17
Locations
29 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT02043197. Inclusion in this directory is not an endorsement.